{"entity":{"type":"insider","cik":"0001709415","url":"/insider/0001709415","json_url":"/insider/0001709415.json","name":"Sapir Alex","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2017-07-07","last":"2024-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Sapir Alex","source":"filing","n_filings":3,"first_seen":"2017-07-07","last_seen":"2024-03-05"}],"transactions":[{"id":2274615,"accession":"0000950170-24-025933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025933","line_url":"/filing/0000950170-24-025933#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001709415","owner_name":"Sapir Alex","owner_display_name":"Sapir Alex","owner_url":"/insider/0001709415","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43360.0,"shares_display":"43,360","price_per_share":11.3475,"price_display":"11.35","price_state":"stated","total_value":492027.6,"total_display":"492,027.60","total_whole":"492,028","shares_owned_after":43360.0,"shares_owned_after_display":"43,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider"},{"id":6868306,"accession":"0001209191-18-046800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-046800","line_url":"/filing/0001209191-18-046800#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals, Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001709415","owner_name":"Sapir Alex","owner_display_name":"Sapir Alex","owner_url":"/insider/0001709415","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21700.0,"shares_display":"21,700","price_per_share":22.83,"price_display":"22.83","price_state":"stated","total_value":495411.0,"total_display":"495,411.00","total_whole":"495,411","shares_owned_after":21700.0,"shares_owned_after_display":"21,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-15","scope":"insider"},{"id":5352265,"accession":"0001209191-17-044261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-044261","line_url":"/filing/0001209191-17-044261#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals, Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001709415","owner_name":"Sapir Alex","owner_display_name":"Sapir Alex","owner_url":"/insider/0001709415","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20100.0,"shares_display":"20,100","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":341700.0,"total_display":"341,700.00","total_whole":"341,700","shares_owned_after":20100.0,"shares_owned_after_display":"20,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001680581","name":"Fulcrum Therapeutics, Inc.","url":"/issuer/0001680581","role":"Director, Officer","n_filings":1,"first_seen":"2024-03-05","last_seen":"2024-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001685071","name":"Dova Pharmaceuticals, Inc.","url":"/issuer/0001685071","role":"Director, Officer (President & CEO)","n_filings":2,"first_seen":"2017-07-07","last_seen":"2018-08-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001709415","retrieved_at":"2026-08-24T18:04:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}